REFERENCES
1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013;382:1575-86.
2. Sani G, Tondo L, Koukopoulos A, Reginaldi D, Kotzalidis GD, Koukopoulos AE, Manfredi G, Mazzarini L, Pacchiarotti I, Simonetti A, Ambrosi E, Angeletti G, Girardi P, Tatarelli R. Suicide in a large population of former psychiatric inpatients. Psychiatry Clin Neurosci 2011;65:286-95.
3. Stertz L, Magalhãs PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 2013;26:19-26.
4. Wagner-Jauregg J. About the effect of fever on psychosis. Jahbuch Psychiatr Neurol 1887;7:94-131.
5. Girgis RR, Kumar SS, Brown AS. The cytokine model of schizophrenia: emerging therapeutic strategies. Biol Psychiatry 2014;75:292-9.
6. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H. Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 2013;25:592-603.
7. Spalletta G, Bossù P, Ciaramella A, Bria P, Caltagirone C, Robinson RG. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006;11:984-91.
8. Spalletta G, Cravello L, Imperiale F, Salani F, Bossù P, Picchetto L, Cao M, Rasura M, Pazzelli F, Orzi F, Caltagirone C, Robinson RG, Cacciari C. Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci 2013;25:255-63.
9. Walker FR. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 2013;67:304-17.
10. Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 2013;65:105-42.
12. Kotzalidis GD, Ambrosi E, Simonetti A, Cuomo I, Del Casale A, Janiri D, Savoja V, Rapinesi C. Neuroinflammation in bipolar disorders. Neuroimmunol Neuroinflamm 2015;2:252-62.
13. Panaccione I, Spalletta G, Sani G. Neuroinflammation and excitatory symptoms. Neuroimmunol Neuroinflamm 2015;2:215-27.
14. Quaranta G, Bucci N, Toni C, Perugi G. Psychotic and non-psychotic mood disorders in autoimmune encephalitis: diagnostic issues and research implications. Neuroimmunol Neuroinflamm 2015;2:228-36.
15. Serra G, De Chiara L, Marangoni C, Faedda GL. The role of neuroinflammation in juvenile bipolar disorder. Neuroimmunol Neuroinflamm 2015;2:244-51.
16. Marangoni C, Nanni MG, Grassi L, Faedda GL. Bipolar disorder preceding the onset of multiple sclerosis: a review. Neuroimmunol Neuroinflamm 2015;2:195-99.
17. Serafini G, Amore M, Rihmer Z. Microstructural brain abnormalities, affective temperaments, and suicidal behavior in patients with major depression. Neuroimmunol Neuroinflamm 2015;2:200-14.
